About:
Arctoris, a tech-enabled biopharma company, believes that the future of drug discovery lies in data-driven research. They combine robotics, data science, and machine learning to make better, faster decisions to bring novel therapeutics in oncology and neurodegeneration to the clinic. Their thorough R&D process involves validating novel targets, identifying hits using computational designs and in vitro screening, developing hits into, and optimizing leads, and taking programs to IND-enabling studies. Arctoris touts its fully automated wet lab and integrated data architecture that can capture and analyze data in real-time using machine learning approaches. Founded in 2016, Arctoris is now headquartered in Oxford and Boston.